VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings83 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

US BANCORP

33.6M$1.5B5.6%$40.84+4.38%
4 qtrssince 2023-Q4
Increased
79

ADOBE INC

2.6M$1.4B4.9%$539.34-4.42%
3 qtrssince 2024-Q1
Increased
67

APPLE INC

4.9M$1.1B4.1%$178.80+29.23%
3 qtrssince 2024-Q1
Increased
62

PHILIP MORRIS INTERNATIONAL

9.1M$1.1B4.0%$86.65+32.98%
6 qtrssince 2023-Q2
Decreased
0

VISA INC-CLASS A SHARES

3.5M$963.9M3.5%$270.870.00%
1 qtr
New
88

SPOTIFY TECHNOLOGY SA

2.6M$949.9M3.5%$358.99+2.84%
2 qtrssince 2024-Q2
Increased
94

FORTIVE CORP - W/I

11.8M$931.2M3.4%$52.54+12.98%
21 qtrssince 2019-Q3
Increased
68

PROGRESSIVE CORP

3.5M$884.6M3.2%$153.93+50.26%
11 qtrssince 2022-Q1
Decreased
0

MICROSOFT CORP

2M$879.7M3.2%$423.40+0.15%
3 qtrssince 2024-Q1
Decreased
0

API GROUP CORP

25.7M$849M3.1%$8.33+169.35%
18 qtrssince 2020-Q2
Decreased
0

WORKDAY INC-CLASS A

3.3M$798.7M2.9%$230.74-13.89%
7 qtrssince 2023-Q1
Decreased
0

BANK OF AMERICA CORP

20M$792M2.9%$38.300.00%
1 qtr
New
82

JPMORGAN CHASE & CO

3.7M$779.5M2.8%$196.58+3.75%
2 qtrssince 2024-Q2
Increased
66

AMAZON.COM INC

4.1M$755.5M2.8%$149.44+25.78%
24 qtrssince 2018-Q4
Decreased
0

BIOMARIN PHARMACEUTICAL INC

9.8M$685.6M2.5%$83.13-15.10%
12 qtrssince 2021-Q4
Increased
71

BRIDGEBIO PHARMA INC

25.1M$639.6M2.3%$26.97-7.53%
22 qtrssince 2019-Q2
Unchanged
0

ROIVANT SCIENCES LTD

54.1M$624.3M2.3%$10.64+7.89%
12 qtrssince 2021-Q4
Decreased
0

FLUTTER ENTMT PLC

2.5M$604M2.2%$238.330.00%
1 qtr
New
81

DOORDASH INC - A

3.6M$513.7M1.9%$108.78+30.75%
2 qtrssince 2024-Q2
Decreased
0

SHERWIN-WILLIAMS CO/THE

1.3M$496.8M1.8%$352.34+7.47%
2 qtrssince 2024-Q2
Increased
80
$27.4B
AUM
83
Positions
Q3 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
+15%Q2'23$24.4B+1%Q3'23$24.6B+11%Q4'23$27.3B-2%Q1'24$26.9B-3%Q2'24$26B+5%Q3'24$27.4B
Activity profile
$ moved · Q3'24
New31%Increased22%Decreased23%Exited24%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q13%1-4Q19%1-2Y7%2Y+60%

VIKING GLOBAL INVESTORS LP manages $27.4B across 83 positions as of Q3 2024. Top holdings: USB (5.6%), ADBE (4.9%), AAPL (4.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2024 Summary

Active quarter - 23 new positions, 22 exits, 21 increased. Top move: SPOT (INCREASED, conviction 94). Portfolio: $27.4B across 83 positions.

Top holdings by portfolio weight

Total AUM$27B
USB5.60%
ADBE4.95%
AAPL4.13%
PM4.01%
V3.51%
SPOT3.46%
FTV3.39%
PGR3.22%
MSFT3.21%
APG3.09%
Other2.91%

Portfolio allocation by GICS sector

Sectors11
Financial Services24.75%
Technology24.45%
Healthcare15.77%
Consumer Cyclical11.68%
Industrials7.03%
Communication Services6.50%
Consumer Defensive4.01%
Real Estate2.39%
Basic Materials2.38%
Utilities0.79%
Other0.24%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Technology, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction49
Concentration54
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VVVISA INC-CLASS A SHARES
Q3 2025 Q2 2026+4.8M shares+$1.6B
3Q
MAAMAAMID-AMERICA APARTMENT COMM
Q4 2025 Q2 2026+2.4M shares+$331.1M
3Q
SESESEA LTD-ADR
Q4 2025 Q2 2026+2.6M shares+$147,561
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used